We hypothesized thatJAK2V617F-negative patients with MPD might have mutations involving other components of the JAK-STAT signal transduction pathway that include cytokine receptors, other JAK family members, or STAT family members. The gene discussed is SOAT1; the disease is myeloproliferative disorder.